Detalhe da pesquisa
1.
Trial of Intravenous Immune Globulin in Dermatomyositis.
N Engl J Med;
387(14): 1264-1278, 2022 10 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36198179
2.
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.
Muscle Nerve;
69(6): 719-729, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38593477
3.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med;
383(10): 919-930, 2020 09 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32877582
4.
Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.
Muscle Nerve;
68(5): 762-766, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37695277
5.
Imaging beyond muscle magnetic resonance imaging in inclusion body myositis.
Clin Exp Rheumatol;
41(2): 386-392, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36700664
6.
Current status of clinical outcome measures in inclusion body myositis: a systematised review.
Clin Exp Rheumatol;
41(2): 370-378, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36762744
7.
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
Muscle Nerve;
65(3): 291-302, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34890069
8.
Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.
Muscle Nerve;
64(3): 243-254, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34260074
9.
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.
Muscle Nerve;
63(3): 371-383, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33340120
10.
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Muscle Nerve;
63(1): 31-39, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33063909
11.
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
Muscle Nerve;
62(2): 156-166, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31899540
12.
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.
Muscle Nerve;
56(5): 901-911, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28063170
13.
A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis.
J Am Acad Dermatol;
84(4): 1160-1162, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32781178
14.
An overview of polymyositis and dermatomyositis.
Muscle Nerve;
51(5): 638-56, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25641317
15.
Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician survey.
Amyotroph Lateral Scler Frontotemporal Degener;
25(1-2): 16-25, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37794794
16.
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Neurol;
23(5): 477-486, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38631764
17.
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lancet Neurol;
2024 May 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38782015
18.
Inclusion Body Myositis.
Continuum (Minneap Minn);
28(6): 1663-1677, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36537974
19.
Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells.
Neurology;
98(13): e1374-e1383, 2022 03 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35131904
20.
Correlations of disease severity outcome measures in inclusion body myositis.
Neuromuscul Disord;
32(10): 800-805, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36050251